CD274 and neoplasm: These results suggest that the inhibition of PD-1/PD-L1 binding in the tumor microenvironment may have anti-tumor effects in cats, and provide the fundamental tools for the establishment of immune checkpoint molecular inhibition therapy in cats as well as in humans and dogs.